Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05608694 · ClinicalTrials.gov registry record · NA
MRI Screening in Men at High Risk of Developing Prostate Cancer
A NA study of Prostate Cancer Screening, sponsored by University of Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 2
- Study locations
NCT05608694: Recruiting NA study of Prostate Cancer Screening, sponsored by University of Chicago.
NCT05608694 is a NA study of Prostate Cancer Screening that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 250 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05608694, a NA study of Prostate Cancer Screening, is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to determine whether or not Magnetic Resonance Images (MRI) will identify high-grade cancers earlier and more frequently in men at high risk of developing prostate cancer.
Primary Outcome
MRI results will be collected every 3 years for 15 years until high grade prostate cancer is detected as defined as Gleason greater than or equal to 7 (Grade Group 2).
Conditions Studied
Interventions
- OTHER Prostate MRI
Study Locations (2)
Illinois
- University of Chicago - Chicago
- NorthShore University Health System - Glenbrook Hospital - Glenview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2022-03-02 |
| Est. Completion | 2039-03-01 |
| Phase | NA |
What NCT05608694 shows while recruiting
NCT05608694 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Prostate Cancer Screening appearing as the primary indexed condition, and to 1 intervention - of which Prostate MRI is the first listed.
NCT05608694 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05608694 about?
NCT05608694 is a clinical study titled "MRI Screening in Men at High Risk of Developing Prostate Cancer". The purpose of this study is to determine whether or not Magnetic Resonance Images (MRI) will identify high-grade cancers earlier and more frequently in men at high risk of developing prostate cancer.
What is the current status of trial NCT05608694?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2022-03-02. Estimated completion is 2039-03-01.
What conditions does trial NCT05608694 study?
This clinical trial studies the following conditions: Prostate Cancer Screening.
What interventions are being tested in trial NCT05608694?
The interventions under investigation include: Prostate MRI (OTHER).
Who is sponsoring clinical trial NCT05608694?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05608694 being conducted?
This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer Screening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05608694's enrollment target sits among peer trials
250 410th of 2000 higher than 1,567 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI